Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification
Background: Curcumin (CUR) displays the capability of suppressing the proliferation and metastasis of various cancer cells. However, the effects and underline mechanisms of CUR to treat triple-negative breast cancer (TNBC) have not been systematically elucidated with an appropriate method.Methods: I...
Saved in:
Main Authors: | Zhicheng Deng (Author), Guanghui Chen (Author), Yonghui Shi (Author), Ying Lin (Author), Jiebin Ou (Author), Hua Zhu (Author), Junyan Wu (Author), Guocheng Li (Author), Li Lv (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation
by: Mengdie Ou, et al.
Published: (2024) -
Comprehensive metrological and content analysis of the income inequality research in health field: A bibliometric analysis
by: Guocheng Xiang, et al.
Published: (2022) -
Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer
by: Zhixuan Wu, et al.
Published: (2024) -
Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
by: Yubao Zhang, et al.
Published: (2021) -
Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
by: Sean M Hacking, et al.
Published: (2023)